MENU
BIOVF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Swedish Orphan Biovitrum AB (BIOVF) Ownership - Who owns Swedish Orphan Biovitrum AB?
Swedish Orphan Biovitrum, or Sobi, focuses on rare diseases, primarily in hematology and immunology... Show more
Profile
Industry
N/A
Address
Tomtebodavagen 23 A
Phone
+46 86972000
Employees
1831
Web
https://www.sobi.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
9.82B
P/E Ratio
21.90
Total Cash
1.06B
Projected Growth
1.81
Total Debt
12.81B
Revenue
26.97B
Risk (Beta)
0.67
Dividend Yield
N/A
Total Cash/Share
3.07
Total Debt/Equity
N/A
Revenue/Share
8.15 USD as % of share price
Fundamentals
BIOVF
Capitalization
9.82B
P/E Ratio
21.90
Risk (Beta)
0.67
Dividend Yield
N/A
Total Cash
1.06B
Total Cash/Share
3.07
Total Debt
12.8B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
1.81
Revenue/Share (as % of the share price)
8.15%
Revenue
27B
ROE
N/A
Book Value
39.1B
P/B Ratio
2.44
Cash Flow
N/A
Earnings
12.76
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
195M
Current Ratio
1.00
Current Revenue Per Employee
3187919.50
Dividends Per Share - Security
N/A
EBITDA
9.77B
Float
N/A
Float - Current
N/A
Gross Income Margin
76.91
Revenue To Assets
6.16
Shares Held By Institutions
19.2B
Shares Outstanding - Current
345M
Total Liabilities
29.7B
Total Volume MTD
N/A
Value
-1
Gain YTD
4.736
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
Industry PharmaceuticalsGeneric
Profile
Fundamentals
Details
Industry
N/A
Address
Tomtebodavagen 23 A
Phone
+46 86972000
Employees
1831
Web
https://www.sobi.com